Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2007
Acute postnatal ablation of Hif-2alpha results in anemiaMichaela Gruber, Cheng-Jun Hu, Randall S Johnson, et al.Plos One|June 2, 2016
Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic ExploitationPatricia Freund, Edit A Porpaczy, Trang Le, et al.International Orthopaedics|March 7, 2025
Outcomes of lateral femoral cutaneous nerve decompression surgery in meralgia paraesthetica: assessment of pain, sensory deficits, and quality of lifeFrancesco Reuter, Karl Schwaiger, Paul Panzenbeck, et al.Annals of Hematology|May 22, 2018
Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patientsEric P Allain, Karin Venzl, Patrick Caron, et al.Genes & Development|April 18, 2007
The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysisJulian J Lum, Thi Bui, Michaela Gruber, et al.STAR Protocols|September 20, 2023
Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editingElisa Ten Hacken, Michaela Gruber, María Hernández-Sánchez, et al.Molecular and Cellular Biology|May 2, 2012
BNip3 regulates mitochondrial function and lipid metabolism in the liverDanielle Glick, Wenshuo Zhang, Michelle Beaton, et al.International Orthopaedics|March 13, 2025
Anatomical variations and their association with carpal tunnel syndrome: a comparison with healthy controlsMichaela Gruber, Agnes Wawrik, Florin Gasser, et al.Leukemia Research|March 13, 2013
Lipoprotein lipase in chronic lymphocytic leukaemia - strong biomarker with lack of functional significanceEdit Porpaczy, Stefanie Tauber, Martin Bilban, et al.Annals of Hematology|May 28, 2011
Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximabMichaela Gruber, Karin Fleiss, Edit Porpaczy, et al.Pageof 4